Tenkasi (previously Orbactiv) Unió Europea - islandès - EMA (European Medicines Agency)

tenkasi (previously orbactiv)

menarini international operations luxembourg s.a. - oritavancin (diphosphate) - soft tissue infections; skin diseases, bacterial - sýklalyf fyrir almenn nota, - tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and paediatric patients aged 3 months and older (see sections 4. 2, 4. 4 og 5. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Ultracortenol Augnsmyrsli 5 mg/g Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

ultracortenol augnsmyrsli 5 mg/g

agepha pharma s.r.o. - prednisolone pivalate - augnsmyrsli - 5 mg/g

Maxidex Augndropar, dreifa 1 mg/ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

maxidex augndropar, dreifa 1 mg/ml

novartis healthcare a/s - dexamethasonum fosfat - augndropar, dreifa - 1 mg/ml

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Unió Europea - islandès - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hinsveiflur og heilahimnubólur og hliðstæður - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Norditropin FlexPro Stungulyf, lausn 5/1,5 mg/ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin flexpro stungulyf, lausn 5/1,5 mg/ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 5/1,5 mg/ml

Norditropin FlexPro Stungulyf, lausn 15/1,5 mg/ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin flexpro stungulyf, lausn 15/1,5 mg/ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 15/1,5 mg/ml

Norditropin FlexPro Stungulyf, lausn 10/1,5 mg/ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin flexpro stungulyf, lausn 10/1,5 mg/ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 10/1,5 mg/ml

Norditropin NordiFlex Stungulyf, lausn í áfylltum lyfjapenna 5 mg /1,5 ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 5 mg /1,5 ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 5 mg /1,5 ml

Norditropin NordiFlex Stungulyf, lausn í áfylltum lyfjapenna 15 mg/1,5 ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

norditropin nordiflex stungulyf, lausn í áfylltum lyfjapenna 15 mg/1,5 ml

novo nordisk a/s* - somatropinum inn - stungulyf, lausn í áfylltum lyfjapenna - 15 mg/1,5 ml

Genotropin Stungulyfsstofn og leysir, lausn 12 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

genotropin stungulyfsstofn og leysir, lausn 12 mg

pfizer aps - somatropinum inn - stungulyfsstofn og leysir, lausn - 12 mg